| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| (S,R,S)-AHPC-C6-NH2 |
(2S,4R)-1-((S)-2-(7-氨基庚酰胺基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2306389-03-5 |
詳細(xì)
|
| 1-METHYL-4-[5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABORALAN-2-YL)PYRIDINE-2-YL]PIPERAZINE |
2-(4-甲基哌嗪-1-基)吡啶-5-硼酸頻那醇酯 |
918524-63-7 |
詳細(xì)
|
| MS4078 |
4-[4-[[5-氯-4-[2-[(1-甲基乙基)磺酰基]氨基]-2-嘧啶基]氨基]-2-甲基-5-(1-甲基乙氧基)苯基]-N-[2-[2-(2,6-二氧代-3-哌啶基)-2,3-二氫-1,3-二氧代-1H-異吲哚-4-基]氨基]乙基]-1-哌啶乙酰胺 |
2229036-62-6 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-NH2 |
(2S,4R)-1 - ((S)-2-(2-(2-(2-氨基乙氧基)乙氧基)乙酰氨基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4- 甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2010159-60-9 |
詳細(xì)
|
| (S,R,S)-AHPC |
(S,R,S)-AHPC |
2055344-67-5 |
詳細(xì)
|
| MZ 1 |
(4R)-N-[14-[(6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-f][1,2,4]三唑[4,3-a][1,4]二氮雜卓-6-基]-1,13-二氧代-3,6,9-三氧雜-12-氮雜十四烷基-1-基] -3-甲基-L-纈氨酰-4-羥基-N-[[[4-(4-甲基-5-噻唑基)苯基]甲基]-L-脯氨酰胺 |
1797406-69-9 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride |
(S,R,S)-AHPC-PEG3-NH2鹽酸鹽 |
2097971-11-2 |
詳細(xì)
|
| (S)-JQ-35 |
1349719-98-7 |
1349719-98-7 |
詳細(xì)
|
| 1-isopropyl-1H-pyrazol-3-amine |
3-氨基-1-異丙基吡唑 |
857267-04-0 |
詳細(xì)
|
| (R)-(-)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate |
(R)-(-)2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜環(huán)庚烷-6-基)乙酸叔丁酯 |
1268524-71-5 |
詳細(xì)
|
| Protein degrader 1 hydrochloride |
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺鹽酸鹽 |
1448189-80-7 |
詳細(xì)
|
| (S,R,S)-AHPC-(C3-PEG)2-C6-Cl |
(S,R,S)-AHPC-C6-PEG1-C3-PEG1-丁基氯 |
1835705-61-7 |
詳細(xì)
|
| PROTAC BET Degrader-1 |
2093386-22-0 |
2093386-22-0 |
詳細(xì)
|
| 3-((1R,3S,5S)-3-((7-((5-Methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile |
3-((1R,3S,5S)-3-((7-((5-甲基-1H-吡唑-3-基)氨基)-1,6-萘啶-5-基)氨基)-8-氮雜雙環(huán)[3.2.1]辛-8-基)丙腈 |
2051918-33-1 |
詳細(xì)
|
| 5-Bromo-2-(4-Boc-piperazin-1-yl)pyridine |
1-(5-溴吡啶-2-基)-4-甲基哌嗪 |
364794-58-1 |
詳細(xì)
|
| 5,8,11-Trioxa-2-azatridecanoic,13-amino,1,1-dimethylethyl ester |
13-氨基-5,8,11-三氧雜-2-氮雜十三烷酸1,1-二甲基乙酯 |
101187-40-0 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG4-NH2 |
(S,R,S)-AHPC-四聚乙二醇-氨基 |
2010159-57-4 |
詳細(xì)
|
| A1874 |
(6S)-N-[1-[4-[[[(2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-(2,2-二甲基丙基)-2-吡咯烷基]羰基]氨基]-3-甲氧基苯基]-1-氧代-5,8,11-三氧雜-2-氮雜十三烷基-13-基]-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜卓-6-乙酰胺 |
2064292-12-0 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-NH2 hydrochloride |
(S,R,S)-AHPC-PEG2-NH2鹽酸鹽 |
2097973-72-1 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG4-N3 |
(S,R,S)-AHPC-四聚乙二醇-疊氮 |
1797406-81-5 |
詳細(xì)
|
| (S,R,S)-AHPC TFA |
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 2,2,2-三氟乙酸鹽 |
1631137-51-3 |
詳細(xì)
|
| (S,R,S)-AHPC-Me TFA |
ZB1965 |
2349429-68-9 |
詳細(xì)
|
| BRD4 degrader AT1 |
2098836-45-2 |
2098836-45-2 |
詳細(xì)
|
| PROTAC BRD9 Degrader-1 |
PROTAC BRD9 DEGRADER-1 |
2097971-01-0 |
詳細(xì)
|
| 3,6,9-trioxaundecamethylenediamine |
3,6,9-三氧雜十一烷-1,11-二胺 |
929-75-9 |
詳細(xì)
|
| 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6R)- |
2-((6R)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F]的[1,2,4 |
202592-24-3 |
詳細(xì)
|
| 2-(2,6-dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione |
4-氟沙度利安 |
835616-61-0 |
詳細(xì)
|
| I-BET762 carboxylic acid |
1300019-38-8 |
1300019-38-8 |
詳細(xì)
|
| dBET57 |
dBET57 |
1883863-52-2 |
詳細(xì)
|
| (S)-AZD6738 |
(S)-CERALASERTIB |
1352226-87-9 |
詳細(xì)
|
| 2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione |
2-(2,6-二氧代-哌啶-3-基)-4-氟基-異吲哚-1,3-二酮 |
835616-60-9 |
詳細(xì)
|
| 1-TOSYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID PINACOL ESTER |
1-[(4-甲基苯基)磺酰基]-4-(4,4,5,5-四甲基-1,3,2-二噁硼 |
916176-50-6 |
詳細(xì)
|
| JQEZ5 |
N-[(1,2-二氫-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-(4-甲基-1-哌嗪基)-3-吡啶基]-1H-吡唑并[3,4-B]吡啶-4-甲酰胺 |
1913252-04-6 |
詳細(xì)
|
| BSJ-03-123 |
BSJ-03-123,CDK6降解劑 |
2361493-16-3 |
詳細(xì)
|
| 5-(6-(3-methoxyoxetan-3-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine |
5-(6-(3-甲氧基氧雜環(huán)丁烷-3-基)-7-甲基-4-嗎啉基噻吩并[3,2-D]嘧啶-2-基)嘧啶-2-胺 |
1394076-92-6 |
詳細(xì)
|
| (3R)-4-(2-chloro-6-(1-((R)-S-methylsulfonimidoyl)cyclopropyl)pyrimidin-4-yl)-3-methylmorpholine |
(3R)-4-(2-氯-6-(1-((R)-S-甲基磺酰亞胺基)環(huán)丙基)嘧啶-4-基)-3-甲基嗎啉 |
1352282-87-1 |
詳細(xì)
|
| (3R)-4-(2-chloro-6-[(methylsulfinyl)methyl]-4-pyrimidinyl)-3-methylmorpholine |
(3R)-4-(2-chloro-6-[(methylsulfinyl)methyl]-4-pyrimidinyl)-3-methylmorpholine |
1352227-18-9 |
詳細(xì)
|
| (3R)-4-[2-chloro-6-(methylsulfanylmethyl)pyrimidin-4-yl]-3-methylmorpholine |
(R)-4-(2-氯-6-((甲硫基)甲基)嘧啶-4-基)-3-甲基嗎啉 |
1352227-15-6 |
詳細(xì)
|
| (R)-4-(2-chloro-6-(iodomethyl)pyrimidin-4-yl)-3-methylmorpholine |
(R)-4-(2-氯-6-(碘甲基)嘧啶-4-基)-3-甲基嗎啉 |
1233339-72-4 |
詳細(xì)
|
| (R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)methyl methanesulfonate |
(R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)methyl methanesulfonate |
1233339-71-3 |
詳細(xì)
|
| (R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)-methanol |
(R)-[2-氯-6-[3-甲基(4-嗎啉基)]-4-嘧啶基]甲醇 |
1233339-70-2 |
詳細(xì)
|
| (R)-methyl 2-chloro-6-(3-methylmorpholino)pyrimidine-4-carboxylate |
(R)-甲基 2-氯-6-(3-甲基嗎啉代)嘧啶-4-羧酸鹽 |
1233339-69-9 |
詳細(xì)
|
| Pomalidomide-PEG4-C-COOH |
14 - ((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異二氫吲哚-4-基)氨基)-3,6, |
2097938-44-6 |
詳細(xì)
|
| E3 Ligase Ligand-Linker Conjugates 20 (TFA) |
N-(8-氨基辛基)-2-((2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-4-基)氧基)乙酰胺2,2,2-三氟乙酸酯 |
1950635-16-1 |
詳細(xì)
|
| E3 Ligase Ligand-Linker Conjugates 25 TFA |
N-(6-氨基己基)-2-((2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-4-基)氧基)乙酰胺2,2,2-三氟乙酸酯 |
1950635-14-9 |
詳細(xì)
|
| Thalidomide-O-amido-PEG3-C2-NH2 |
薩力多胺-O-酰胺-三聚乙二醇-氨基 |
1957236-20-2 |
詳細(xì)
|
| E3 Ligase Ligand-Linker Conjugates 2 |
泊馬度胺-四聚乙二醇-苯胺 |
1818885-63-0 |
詳細(xì)
|
| (S,R,S)-AHPC-C4-NH2 hydrochloride |
(4R)-N-(5-氨基-1-氧雜戊基)-3-甲基-L-戊基-4-羥基-N-[[4-(4-甲基-5-噻唑基)苯基]甲基]-L-脯氨酰胺 鹽酸鹽 |
2245697-83-8 |
詳細(xì)
|
| VH032-PEG3-acetylene |
VH 032 酰胺-PEG2-炔 |
2098799-80-3 |
詳細(xì)
|
| 1-ISOPROPYL-3-METHYL-6-OXO-6,7-DIHYDRO-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID |
1-異丙基-3-甲基-6-氧代-6,7-二氫-1H-吡唑并[3,4-B]吡啶-4-甲酸 |
1160246-29-6 |
詳細(xì)
|
| ARV-771 |
(2S,4R)-1-((2S)-2-(叔丁基)-15-((6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜卓-6-基)-4,14-二氧代-6,10-二氧雜-3,13-二氮雜十五烷-1-OYL)-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺 |
1949837-12-0 |
詳細(xì)
|
| E3 ligase Ligand-Linker Conjugates 7 |
(S,R,S)-AHPC-四聚乙二醇-氨基鹽酸鹽 |
2064292-52-8 |
詳細(xì)
|
| 2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione |
4-羥基沙利度胺 |
64567-60-8 |
詳細(xì)
|
| E3 ligase Ligand-Linker Conjugates 5 Free Base |
(2S,4R)-1-[(S)-14-氨基-2-(叔丁基)-4-氧代-6,9,12-三氧雜-3-氮雜十四烷-1-?；鵠-4-羥基-N-[4-(4-甲基-5-噻唑基)芐基]吡咯烷-2-甲酰胺 |
2010159-56-3 |
詳細(xì)
|
| (S,R,S)-AHPC-Me-C6-NH2 |
|
2411422-49-4 |
詳細(xì)
|
| (S,R,S)-AHPC-C10-NH2 dihydrochloride |
(2S,4R)-1-((S)-2-(11-氨基戊酰胺基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺二鹽酸鹽 |
2341796-75-4 |
詳細(xì)
|
| (S,R,S)-AHPC-C4-NH2 |
(2S,4R)-1-((S)-2-(5-氨基戊氨基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2138439-53-7 |
詳細(xì)
|
| 4-[5-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDIN-2-YL]-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
4-[5-(4,4,5,5-四甲基-1,3,2-DIOXABOROLAN-2-基)哌啶-2-基]哌嗪-1-羧酸叔丁酯 |
496786-98-2 |
詳細(xì)
|
| MDK7526 |
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰)-4-羥基-N-(4-(4-甲基噻唑-5-基)苯甲基)吡咯烷-2-甲酰胺 |
1448297-52-6 |
詳細(xì)
|
| E3 ligase Ligand 1A |
L-脯氨酰胺,3-甲基-1-纈氨酸-4-羥基-N-[(1S)-1-[4-(4-甲基-5-噻唑基)苯基]乙基]-,(4R)- |
1948273-02-6 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG1-N3 |
(4R)-N-[2-(2-疊氮乙氧基)乙酰基]-3-甲基-L-纈氨?；?4-羥基-N-[[4-(4-甲基-5-噻唑基)苯基]甲基]-L-脯氨酸酰胺 |
2101200-09-1 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG3-N3 |
(S,R,S)-AHPC-三聚乙二醇-疊氮 |
1797406-80-4 |
詳細(xì)
|
| 4-(3-Pyridyl)-2-chloropyrimidine |
4-(3-吡啶基)-2-氯嘧啶 |
483324-01-2 |
詳細(xì)
|
| AP20187 |
AP 20187,蛋白質(zhì)二聚化的化學(xué)誘導(dǎo)劑 |
195514-80-8 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-N3 |
(S,R,S)-AHPC-二聚乙二醇-疊氮 |
2010159-45-0 |
詳細(xì)
|
| (S,R,S)-AHPC-C3-NH2 |
VH032-C3-NH2 |
2361119-88-0 |
詳細(xì)
|
| (S,R,S)-AHPC-Me-C5-COOH |
7-(((S)-1-((2S,4R)-4-羥基-2-(((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)氨基甲酰基)吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)氨基)-7-氧代庚酸 |
2229976-21-8 |
詳細(xì)
|
| (S,R,S)-AHPC-C5-COOH |
VH032-C5-COOH |
2267282-19-7 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-NH2 dihydrochloride |
(S,R,S)-AHPC-PEG2-NH2二鹽酸鹽 |
2341796-76-5 |
詳細(xì)
|
| (S,R,S)-AHPC-O-Ph-PEG1-NH2 |
(2S,4R)-1-((S)-2-(2-(4-(2-氨基乙氧基)苯氧基)乙酰胺基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2361117-24-8 |
詳細(xì)
|
| (S,R,S)-AHPC-C4-NH2 dihydrochloride |
(S,R,S)-AHPC-C4-氨基-二鹽酸鹽 |
2341796-78-7 |
詳細(xì)
|
| (S,R,S)-AHPC-Me-C10-NH2 |
(2S,4R)-1-((S)-2-(11-氨基十一酰胺)-3,3-二甲基丁?；?-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5)-基)苯基)乙基)吡咯烷-2-甲酰胺 |
2376139-52-3 |
詳細(xì)
|
| (S,R,S)-AHPC-C10-NH2 |
VH032-C10-NH2 |
2341796-74-3 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG5-COOH |
VH 032 酰胺-PEG5-酸 |
2172820-14-1 |
詳細(xì)
|
| Thalidomide-O-amido-C4-N3 |
沙利度胺 4'-氧乙酰胺-烷基C4-疊氮化物 |
2098488-36-7 |
詳細(xì)
|
| Thalidomide-O-amido-C3-COOH |
4-(2-((2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-4-基)氧基)乙酰氨基)丁酸 |
2308035-51-8 |
詳細(xì)
|
| Thalidomide-O-amido-PEG2-C2-NH2 TFA |
沙利度胺-O-酰胺-二聚乙二醇-氨基三氟乙酸鹽 |
1957235-75-4 |
詳細(xì)
|
| E3 Ligase Ligand-Linker Conjugates 52 (TFA) |
N-(3-氨基丙基)-2-[[2-(2,6-二氧代-3-哌啶基)-1,3-二氧代-4-異吲哚啉基]氧基]乙酰胺三氟乙酸鹽 |
2022182-58-5 |
詳細(xì)
|
| Pomalidomide-PEG3-C2-NH2 |
4-((2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙基)氨基)-2-(2,6-二氧代-哌啶-3-基)異吲哚-1,3-二酮 |
2093416-31-8 |
詳細(xì)
|
| Pomalidomide-C2-NH2 hydrochloride |
泊馬度胺-C2-氨基鹽酸鹽 |
2305369-00-8 |
詳細(xì)
|
| Thalidomide-O-amido-C4-NH2 hydrochloride |
薩力多胺-O-酰胺-C4-氨基鹽酸鹽 |
2245697-86-1 |
詳細(xì)
|
| Pomalidomide-PEG1-C2-N3 |
E3 ligase Ligand-Linker Conjugates 50 |
2271036-44-1 |
詳細(xì)
|
| Thalidomide-O-amido-C6-NH2 hydrochloride |
沙利度胺-氧乙酰胺-C6-氨基鹽酸鹽 |
2376990-31-5 |
詳細(xì)
|
| Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride |
薩力多胺-O-酰胺-四聚乙二醇-氨基鹽酸鹽 |
2245697-85-0 |
詳細(xì)
|
| Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride |
薩力多胺-O-酰胺-三聚乙二醇-氨基鹽酸鹽 |
2245697-84-9 |
詳細(xì)
|
| Pomalidomide-amido-PEG3-C2-NH2 |
E3 ligase Ligand-Linker Conjugates 55 |
2328070-52-4 |
詳細(xì)
|
| Thalidomide-O-amido-PEG-C2-NH2 hydrochloride |
薩力多胺-O-酰胺-一聚乙二醇-氨基鹽酸鹽 |
2204226-02-6 |
詳細(xì)
|
| Thalidomide-NH-C4-NH2 TFA |
薩力多胺-NH-C4-氨基三氟乙酸鹽 |
2093387-50-7 |
詳細(xì)
|
| Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride |
沙利度胺-O-酰胺-二聚乙二醇-氨基鹽酸鹽 |
2376990-30-4 |
詳細(xì)
|
| Thalidomide-NH-C4-NH-Boc |
泊馬度胺-NH-C4-氨基叔丁酯 |
2093388-52-2 |
詳細(xì)
|
| (S,R,S)-AHPC-Me hydrochloride |
(2S,4R)-1-[(2S)-2-氨基-3,3-二甲基丁酰]-4-羥基-N-[(1S)-1-[4-(4-甲基-1,3-噻唑-5-基)苯基]乙基]吡咯烷-2-甲酰胺鹽酸 |
1948273-03-7 |
詳細(xì)
|
| PROTAC BRD4 Degrader-5 |
|
2409538-70-9 |
詳細(xì)
|
| CCT367766 |
CCT-367766 |
2229856-58-8 |
詳細(xì)
|
| (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylicacid |
(2S,4R)-1-((S)-2-((叔丁氧基羰基)氨基)-3,3-二甲基丁?；?-4-羥基吡咯烷-2-甲酸 |
630421-46-4 |
詳細(xì)
|
| TD-165 |
(2S,4R)-1-((2S)-2-(11-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)氨基)十一酰胺基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2305936-56-3 |
詳細(xì)
|
| MS1943 |
2-(氨基甲基)-1,6-二甲基-3-(苯基甲氧基)-4(1H)-吡啶酮 |
2225938-17-8 |
詳細(xì)
|
| PROTAC SGK3 degrader-1 |
SGK3 degrader-1 |
2381320-35-8 |
詳細(xì)
|
| PROTAC K-Ras Degrader-1 |
PROTAC K-RAS DEGRADER-1 |
2378258-52-5 |
詳細(xì)
|
| DT2216 |
(2S,4R)-1-((S)-2-(7-(4-((R)-3-((4-(N-(4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氫-[1,1'-聯(lián)苯]-2-基)甲基)哌嗪-1-基)苯甲酰基)氨磺?；?-2-((三氟甲基)磺?；?苯基)氨基)-4-(苯硫基)丁基)哌嗪-1-基)-7-氧代庚酰胺基)-3,3-二甲基丁?；?-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺 |
2365172-42-3 |
詳細(xì)
|
| VH032-PEG5-C6-Cl |
1799506-06-1 |
1799506-06-1 |
詳細(xì)
|